These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20386458)

  • 1. AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog.
    Burashnikov A; Zygmunt AC; Di Diego JM; Linhardt G; Carlsson L; Antzelevitch C
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):80-90. PubMed ID: 20386458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
    Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
    Circulation; 2007 Sep; 116(13):1449-57. PubMed ID: 17785620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
    Burashnikov A; Belardinelli L; Antzelevitch C
    J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
    Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.
    Burashnikov A; Petroski A; Hu D; Barajas-Martinez H; Antzelevitch C
    Heart Rhythm; 2012 Jan; 9(1):125-31. PubMed ID: 21884675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
    Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
    Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves.
    Sicouri S; Carlsson L; Antzelevitch C
    J Pharmacol Exp Ther; 2010 Jul; 334(1):255-9. PubMed ID: 20360353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
    Burashnikov A; Di Diego JM; Sicouri S; Ferreiro M; Carlsson L; Antzelevitch C
    Heart Rhythm; 2008 Dec; 5(12):1735-42. PubMed ID: 19084813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.
    Aguilar-Shardonofsky M; Vigmond EJ; Nattel S; Comtois P
    Biophys J; 2012 Mar; 102(5):951-60. PubMed ID: 22404917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts.
    Chu Y; Yang Q; Ren L; Yu S; Liu Z; Chen Y; Wei X; Huang S; Song L; Zhang P; Ma J; Wu L
    J Cardiovasc Pharmacol; 2020 Oct; 76(4):437-444. PubMed ID: 32675747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
    Sicouri S; Burashnikov A; Belardinelli L; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):88-95. PubMed ID: 19952329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.
    Burashnikov A; Barajas-Martinez H; Hu D; Nof E; Blazek J; Antzelevitch C
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):539-46. PubMed ID: 22370957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial-selective sodium channel blockers: do they exist?
    Burashnikov A; Antzelevitch C
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):121-8. PubMed ID: 18670368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
    Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial-selective block of sodium channels by acehytisine in rabbit myocardium.
    Fan X; Wang C; Wang N; Ou X; Liu H; Yang Y; Dang X; Zeng X; Cai L
    J Pharmacol Sci; 2016 Dec; 132(4):235-243. PubMed ID: 27107824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2010 Sep; 7(9):1273-9. PubMed ID: 20478403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogs.
    Varga RS; Hornyik T; Husti Z; Kohajda Z; Krajsovszky G; Nagy N; Jost N; Virág L; Tálosi L; Mátyus P; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2021 Jan; 99(1):89-101. PubMed ID: 32970956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
    Johnson DM; de Jong MM; Crijns HJ; Carlsson LG; Volders PG
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):201-9. PubMed ID: 22080293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo.
    Jacobson I; Duker G; Florentzson M; Linhardt G; Lindhardt E; Nordkam AK; Åstrand A; Carlsson L
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):290-300. PubMed ID: 23307834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.